1655501-53-3

1655501-53-3 structure

Name: Fremanezumab
Chemical Name: Fremanezumab
CAS Number: 1655501-53-3
Molecular Formula:
Molecular Weight:
Catalog: Signaling Pathways GPCR/G Protein CGRP Receptor
Create Date: 2018-06-08 15:51:05
Modify Date: 2024-01-28 02:39:38
Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research[1].

Name	Fremanezumab

Description	Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research[1].
Related Catalog	Signaling Pathways >> GPCR/G Protein >> CGRP Receptor Signaling Pathways >> Neuronal Signaling >> CGRP Receptor Research Areas >> Neurological Disease
References	[1]. Stephen D Silberstein, et al. Fremanezumab for the Preventive Treatment of Chronic Migraine. N Engl J Med. 2017 Nov 30;377(22):2113-2122.

No Any Chemical & Physical Properties